Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study

2012562 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 381, Issue 9861, pp. 117-124

Field-Weighted Citation Impact: 39.96